Published in J Cereb Blood Flow Metab on December 01, 1999
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest (1999) 2.08
TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods (2009) 1.86
Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol (2011) 1.46
Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke (2007) 1.02
Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res (2005) 0.95
Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives. J Cereb Blood Flow Metab (2011) 0.94
Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab (2005) 0.92
Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. Eur J Neurosci (2014) 0.92
Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am (2011) 0.90
Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent. Stroke (2011) 0.88
Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit. Sensors (Basel) (2013) 0.87
Translational MR Neuroimaging of Stroke and Recovery. Transl Stroke Res (2016) 0.77
The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet (1993) 5.97
Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999) 5.81
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (2001) 3.27
A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (1989) 3.21
Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science (1989) 3.06
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res (1999) 2.70
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A (1998) 2.68
Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes. Cell (1987) 2.36
The human photoreceptor membrane guanylyl cyclase, RetGC, is present in outer segments and is regulated by calcium and a soluble activator. Neuron (1994) 2.28
Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science (1991) 2.25
Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) (1997) 2.14
Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke (1997) 2.14
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest (1999) 2.08
Chromatin fibers are left-handed double helices with diameter and mass per unit length that depend on linker length. Biophys J (1986) 2.02
A role for leptin and its cognate receptor in hematopoiesis. Curr Biol (1996) 1.99
Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest (1991) 1.91
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell Melanoma Res (2007) 1.80
Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature (1989) 1.79
Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest (1998) 1.76
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol (1989) 1.72
Current views on cervical intraepithelial neoplasia. J Clin Pathol (1991) 1.72
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) (1993) 1.69
Guanylyl cyclase receptors. J Biol Chem (1994) 1.64
Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol (1996) 1.63
Membrane guanylate cyclase is a cell-surface receptor with homology to protein kinases. Nature (1988) 1.62
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging (2002) 1.59
Molecular cloning of a retina-specific membrane guanylyl cyclase. Neuron (1992) 1.56
Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother (1996) 1.52
Gene expression analysis by transcript profiling coupled to a gene database query. Nat Biotechnol (1999) 1.50
Hematopoietic defects in mice lacking the sialomucin CD34. Blood (1996) 1.46
R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene (1994) 1.42
Molecular cloning and analysis of DNA complementary to three mouse Mr = 68,000 heat shock protein mRNAs. J Biol Chem (1986) 1.42
Lymphocytic hypophysitis: unusual features of a rare disorder. Clin Endocrinol (Oxf) (1995) 1.41
Use of terminology questioned. Br Dent J (1999) 1.39
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
Outpatient vulval biopsy--a note of caution. Br J Obstet Gynaecol (1995) 1.38
Tamoxifen and the gynaecologist. Br J Obstet Gynaecol (1993) 1.38
Wound recurrence by implantation of a borderline ovarian tumour following laparoscopic removal. Br J Obstet Gynaecol (1994) 1.37
Surviving a viva: a guide for candidates. J R Soc Med (2004) 1.37
Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem J (1996) 1.37
Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest (1998) 1.36
The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci (1995) 1.34
Mortality of workers at a nickel carbonyl refinery, 1958-2000. Occup Environ Med (2005) 1.33
A new member of a family of site-specific retrotransposons is present in the spliced leader RNA genes of Trypanosoma cruzi. Mol Cell Biol (1991) 1.31
Mouse and Drosophila genes encoding the major heat shock protein (hsp70) are highly conserved. Mol Cell Biol (1983) 1.30
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab (2000) 1.26
Proteins related to the mouse L-cell major heat shock protein are synthesized in the absence of heat shock gene expression. Proc Natl Acad Sci U S A (1984) 1.24
Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem (1991) 1.24
Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure. Stroke (1992) 1.23
Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy. J Mol Cell Cardiol (1998) 1.21
Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet (2001) 1.21
Cytogenetic, biochemical, and molecular analyses of a 22q13 deletion. Am J Med Genet (1992) 1.21
A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut (1995) 1.20
Selective and divided Attention in a Stroop task. Can J Psychol (1982) 1.18
The major heat-shock protein (hsp70) gene family: related sequences in mouse, Drosophila, and yeast. Can J Biochem Cell Biol (1983) 1.17
Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut (1992) 1.16
Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem (1999) 1.14
Intracardiac metastases from neuroendocrine tumours. Clin Endocrinol (Oxf) (1997) 1.14
Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex. Protein Sci (1997) 1.12
The diameters of frozen-hydrated chromatin fibers increase with DNA linker length: evidence in support of variable diameter models for chromatin. J Cell Biol (1990) 1.12
Resistance of filarial nematode parasites to oxidative stress. Int J Parasitol (1998) 1.11
A gender-specific intervention for at-risk women in the USA. AIDS Care (2000) 1.10
Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging (1997) 1.10
Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation (2000) 1.09
Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biol (1992) 1.09
Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res (1995) 1.09
Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol (1991) 1.08
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer (2002) 1.08
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab (1999) 1.08
A model for quantification of perfusion in pulsed labelling techniques. NMR Biomed (1996) 1.06
Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc Natl Acad Sci U S A (1999) 1.06
Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab (1998) 1.05
Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab (1996) 1.05
The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.04
Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol (1989) 1.04
Basal cell carcinoma of the vulva: a clinicopathologic study of 45 cases. Int J Gynecol Pathol (1997) 1.04
Paraneoplastic syndromes in patients with ovarian neoplasia. J R Soc Med (1993) 1.04
Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem (1996) 1.04
Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum (1994) 1.03
Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation (2001) 1.03
Transient focal cerebral ischemia induces sensorimotor deficits in mice. Behav Brain Res (2000) 1.03
Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei. Exp Parasitol (1999) 1.03
The hemodynamic effects of endothelin-1 in the pithed rat. J Cardiovasc Pharmacol (1989) 1.02
q-Space imaging of the brain. Magn Reson Med (1994) 1.02
Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the pithed rat. Br J Pharmacol (1987) 1.01
Field evaluation of a rapid, simple and inexpensive urease test for the detection of Helicobacter pylori. J Gastroenterol Hepatol (1993) 1.00
Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J Cardiovasc Pharmacol (1989) 1.00
Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf) (1990) 0.99
DNA markers for the diagnosis of Wilson disease. J Hepatol (1993) 0.98
Magnetic resonance imaging assessment of cerebral hemodynamics during spreading depression in rats. J Cereb Blood Flow Metab (1998) 0.97